Clinical Trials Browser

Uterine Cervical Neoplasms × Watchful Waiting × Clear all

NCT06815939 2026-01-29

OPTICS

Phase NA Recruiting

10,000 enrolled

GynecologicOther neoplasm

Urogenital Diseases, Genital Diseases, Uterine Cervical Diseases, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Female, Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Precancerous Conditions, Urogenital Neoplasms, Uterine Diseases, Uterine Neoplasms

NCT06411938 2026-01-16

Merck-3

Phase NA Active not recruiting

Uterine Cervical Neoplasms

NCT03220009 2018-10-03

Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma

Phase 2 Withdrawn

DermatologicGastrointestinalGynecologic

Uterine Cervical Neoplasms, Esophageal Neoplasms, Melanoma, Vaginal Neoplasms, Vulvar Neoplasms

NCT02029794 2017-05-03

ASPIRE

Phase NA Completed

Uterine Cervical Neoplasms

NCT02237326 2014-09-11

SAVE

Phase NA Completed

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT00632047 2013-08-26

Early Detection of Breast Cancer and Cervical Cancer in Women in India

Phase 2 Unknown

151,538 enrolled

BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms